| Literature DB >> 27852234 |
Nathan John Lachowsky1,2, Justin Tyler Sorge3, Henry Fisher Raymond4,5, Zishan Cui3, Paul Sereda3, Ashleigh Rich3, Eric A Roth6, Robert S Hogg3,7, David M Moore3,8.
Abstract
BACKGROUND: Respondent-driven sampling (RDS) is an increasingly used peer chain-recruitment method to sample "hard-to-reach" populations for whom there are no reliable sampling frames. Implementation success of RDS varies; one potential negative factor being the number of seeds used.Entities:
Keywords: HIV/AIDS; Men who have sex with men; Respondent-driven sampling; Sensitivity analysis
Mesh:
Year: 2016 PMID: 27852234 PMCID: PMC5112687 DOI: 10.1186/s12874-016-0258-4
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Momentum Health Study recruitment tree. Nodes represent one study recruit. Seeds are represented by superior terminus nodes
Wave-length characteristics of four differing sample restrictions based on seed productivity
| Overall ( | >0 Wave ( | >1 Wave ( | >2 Waves ( | |
|---|---|---|---|---|
| Seedsa
| 119 (16.6%) | 69 (10.3%) | 37 (6.2%) | 25 (4.7%) |
| Wave length mean (median) | 1.75 (1.00) | 3.01 (2.00) | 4.76 (3.00) | 6.08 (5.00) |
| Wave length range | 0–16 | 1–16 | 2–16 | 3–16 |
aNumber of seeds corresponds with number of chains
Momentum Health Study sample demographics
|
| Crude % | |
|---|---|---|
| Sexual identity | ||
| Gay | 612 | 85.1 |
| Bisexual/Other | 107 | 14.9 |
| Age (years) | ||
| 18–29 | 275 | 38.3 |
| 30–44 | 233 | 32.4 |
| ≥ 45 | 211 | 29.5 |
| Race/Ethnicity | ||
| White | 539 | 75.0 |
| Asian | 72 | 10.0 |
| Indigenous | 50 | 7.0 |
| Other | 58 | 8.1 |
| Income (CAD) | ||
| < $30,000 | 457 | 63.6 |
| $30,000–60,000 | 182 | 25.3 |
| > $60,0000 | 80 | 11.1 |
| Regular sex partner | ||
| Yes | 273 | 37.0 |
| No | 446 | 62.3 |
| Number of male anal sex partners in past 6 months | ||
| 0 | 89 | 12.4 |
| 1–2 | 226 | 31.5 |
| 3–6 | 208 | 30.0 |
| ≥ 7 | 195 | 27.2 |
Fig. 2Convergence and bottleneck plots of three key outcome variables of the Momentum Health Study. Plot y-axes represent proportions of participants that answered “yes” to the parameter, x-axes are number of participants. P6M = past six months, IDU = injection drug use, excluding steroids
Three key study outcomes using various sample cuts and RDS-weights
|
| Crude % | RDS I % (95% CI) | RDS II % (95% CI) | RDS SS % (95% CI) | ||
|---|---|---|---|---|---|---|
| HIV-positive serostatus (vs. HIV-negative) | Overall | 199 | 27.7 | 22.5 (19.4–25.6) | 26.7 (20.7–32.7) | 26.7 (20.7–32.7) |
| >0 Wave | 189 | 28.3 | 22.9 (19.7–26.2) | 27.7 (21.5–33.9) | 27.7 (21.4–34.1) | |
| >1 Wave | 178 | 30.0 | 24.2 (20.6–27.7) | 29.3 (22.6–36.0) | 29.4 (22.6–36.1) | |
| >2 Wave | 161 | 30.0 | 23.8 (20.1–27.5) | 29.1 (22.1–36.1) | 29.1 (22.1–36.2) | |
| Any high risk sex in past 6 months (vs. none) | Overall | 262 | 37.3 | 34.9 (31.1–38.8) | 33.6 (27.6–39.6) | 33.7 (27.7–39.7) |
| >0 Wave | 251 | 38.4 | 35.5 (31.5–39.5) | 35.2 (28.9–41.5) | 35.3 (29.0–41.6) | |
| >1 Wave | 221 | 38.0 | 36.0 (31.7–40.3) | 35.8 (29.3–42.4) | 35.8 (29.2–42.4) | |
| >2 Wave | 203 | 38.7 | 37.0 (32.4–41.5) | 36.4 (29.5–43.3) | 36.5 (29.6–43.3) | |
| Injected any drugs in past 6 months (vs. none) | Overall | 61 | 7.1 | 8.8 (5.5–12.1) | 7.3 (3.9–10.7) | 7.3 (3.9–10.7) |
| >0 Wave | 51 | 7.6 | 9.1 (5.8–12.4) | 8.1 (4.4–11.8) | 8.1 (4.3–11.9) | |
| >1 Wave | 48 | 8.1 | 8.7 (5.7–11.7) | 8.0 (4.7–11.3) | 8.0 (4.7–11.3) | |
| >2 Wave | 43 | 8.0 | 8.7 (5.5–11.9) | 8.3 (4.8–11.8) | 8.3 (4.8–11.9) |
Paired comparison of RDS weights for three key study outcomes
| Crude | RDS-I | RDS-II | RDS-SS | RDS-II – RDS-I | RDS-SS – RDS-I | RDS-SS – RDS-II | |
|---|---|---|---|---|---|---|---|
| HIV-positive serostatus | |||||||
| Mean % (95% CI) | 27.0 (12.3–39.3) | 22.2 (10.3–31.9) | 25.7 (10.7–36.3) | 25.7 (10.7–36.3) | 3.4 (−0.9–7.5) | 3.4 (−0.9–7.5) | 0.0 (−) |
|
| 0.11 | 0.11 | 0.22 | ||||
| Any high risk sex in past 6 months | |||||||
| Mean % (95% CI) | 37.0 (32.2–41.9) | 34.3 (26.7–41.4) | 33.1 (25.3–39.4) | 33.1 (25.3–39.4) | −1.2 (−2.9–0.3) | −1.2 (−2.9–0.3) | 0.0 (0.0–0.1) |
|
| 0.12 | 0.12 | 0.28 | ||||
| Injected any drugs in past 6 months | |||||||
| Mean % (95% CI) | 6.6 (2.6–11.3) | 9.0 (2.3–14.0) | 6.7 (1.8–11.7) | 6.7 (1.8–11.6) | −2.3 (−3.0–0.0) | −2.3 (−3.0–0.0) | 0.0 (−) |
|
| 0.06 | 0.06 | 0.18 | ||||